92 results
8-K
EX-99.1
NDRA
ENDRA Life Sciences Inc
6 Jun 24
ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering
8:00am
; expectations concerning ENDRA’s business strategy; and statements regarding ENDRA’s ability to find and maintain development partners. Forward-looking statements
424B3
NDRA
ENDRA Life Sciences Inc
5 Jun 24
Prospectus supplement
8:20am
,” “may,” “will,” “should,” “would,” “could,” “seek,” “intend,” “plan,” “goal,” “project,” “estimate,” “anticipate,” “strategy”, “future”, “likely … financial position and projected costs and revenue; expectations concerning our business strategy; and statements regarding our ability to find and maintain
8-K
EX-99.1
NDRA
ENDRA Life Sciences Inc
20 May 24
ENDRA Provides Update Following In-person Meeting with FDA
8:05am
strategy; and statements regarding ENDRA’s ability to find and maintain development partners. Forward-looking statements involve inherent risks
8-K
EX-99.1
ycph6yz0vig6
14 May 24
ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update
4:17pm
424B5
pf3jc4cdp 62taqdfve
3 Apr 24
Prospectus supplement for primary offering
5:15pm
424B5
0g40j9xyrfxozhit il
3 Apr 24
Prospectus supplement for primary offering
5:14pm
8-K
EX-99.1
pn4e73geru0j2jm
28 Mar 24
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:10pm
8-K
EX-99.1
hsrypc wv97kk1o
14 Nov 23
ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
4:02pm
8-K
EX-99.1
4myl4qn rxj04sn
14 Aug 23
ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update
4:13pm
8-K
EX-99.2
phjv7 zkm
14 Aug 23
ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update
4:13pm